Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
Column Group IV GP, LP (CIK 1796356) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-08). Recent activity: Buy EIKN (89,200 shares), Buy EIKN (1.3M shares), Buy EIKN (1.4M shares), Buy EIKN (110,928 shares), Buy EIKN (44,249 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-08 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 89,200 | $1.0M |
| 2026-02-09 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 1.3M | $0 |
| 2026-02-09 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 1.4M | $0 |
| 2026-02-09 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 110,928 | $0 |
| 2026-02-09 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 44,249 | $0 |
| 2026-02-09 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 47,898 | $0 |
| 2026-02-09 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 3,785 | $0 |
| 2026-02-09 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 688,283 | $0 |
| 2026-02-09 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 1.4M | $25.9M |
| 2026-02-09 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 49,556 | $892,008 |
| 2026-02-09 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 630,881 | $11.4M |
Source: SEC Form 4 filings · as of 2026-09-08